NCT00437268 2020-07-21A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerEli Lilly and CompanyPhase 2 Completed26 enrolled 19 charts
NCT00612586 2020-07-21Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerEli Lilly and CompanyPhase 2 Completed117 enrolled 15 charts